Literature DB >> 2122936

Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma.

J A Brieva1, L M Villar, G Leoro, J C Alvarez-Cermeño, E Roldán, P Gonzalez-Porqué.   

Abstract

HLA class I antigens are thought to be integral membrane proteins. However, soluble forms of these molecules have been detected. Our laboratory has recently shown that the predominant form of these soluble proteins present in human serum, spleen tissue and culture supernatant of activated lymphocytes exhibits molecular weight and structure similar to classical HLA class I antigens, but lacks HLA A or B polymorphic determinants. In the present study, the secretion of such soluble proteins by lymphocytes has been further explored. Phytohaemagglutinin-stimulated normal lymphocytes secrete considerable quantities of soluble HLA (sHLA) class I proteins. This secretion seems to be a general property of lymphocytes, since activation of T as well as B cells by appropriate mitogens equally induce sHLA I secretion. Lymphocytes require RNA and protein synthesis, but not DNA synthesis, for the secretion to occur. Kinetic studies reveal that maximal sHLA I secretion precedes the peak of DNA synthesis by 24 h. In vitro stimulation with antigens or alloantigens also provokes sHLA I secretion. Moreover, this phenomenon has also been detected for in vivo-activated lymphocytes, as enhanced spontaneous sHLA I secretion was observed in cultures of low-density blastic B and T cells, and of blood lymphocytes obtained from normal subjects who had received a booster immunization 5 days earlier. Interferon-gamma (IFN-gamma) increases the expression of membrane-bound class I antigens but does not induce any sHLA I secretion, suggesting that both molecules are under different regulatory mechanisms. Our results indicate that human lymphocytes, upon stimulation, actively secrete considerable amounts of a soluble form of these biologically relevant proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2122936      PMCID: PMC1535119          DOI: 10.1111/j.1365-2249.1990.tb05459.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

Review 1.  MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

Authors:  R M Zinkernagel; P C Doherty
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture.

Authors:  L M Villar; G Roy; I Lázaro; J C Alvarez-Cermeno; M González; J A Brieva; M L Del la Sen; G Leoro; A Bootello; P González-Porqué
Journal:  Eur J Immunol       Date:  1989-10       Impact factor: 5.532

3.  Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments.

Authors:  P Cresswell; M J Turner; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

Review 4.  Structure of class I major histocompatibility antigens.

Authors:  E S Kimball; J E Coligan
Journal:  Contemp Top Mol Immunol       Date:  1983

5.  Secretion of a transplantation-related antigen.

Authors:  M Kress; D Cosman; G Khoury; G Jay
Journal:  Cell       Date:  1983-08       Impact factor: 41.582

6.  DNA synthesis in subpopulations of blood mononuclear leucocytes in human subjects after vaccination against yellow fever.

Authors:  A Ehrnst; B Lambert; A Fagraeus
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

7.  Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

8.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.

Authors:  C J Barnstable; W F Bodmer; G Brown; G Galfre; C Milstein; A F Williams; A Ziegler
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

9.  Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon.

Authors:  I Heron; M Hokland; K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Frequency of B lymphocytes responsive to anti-immunoglobulin.

Authors:  A L Defranco; E S Raveche; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  11 in total

1.  Inhibition of Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro.

Authors:  B Gansuvd; M Hagihara; B Munkhbat; N Kanai; N Morita; N Munkhtuvshin; J Chargui; S Kato; T Hotta; K Tsuji
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

2.  Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment.

Authors:  F Puppo; F Torre; P Contini; M Ghio; S Brenci; R Brizzolara; N Sinelli; N Campo; F Indiveri; A Picciotto
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

3.  Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy.

Authors:  Giuseppe Murdaca; Paola Contini; Paola Cagnati; Simona Marenco; Giulia Pieri; Francesca Lantieri; Antonino Picciotto; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-11-14       Impact factor: 3.984

4.  High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction?

Authors:  K T Nouri Aria; M Lombard; R Williams
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

5.  Bio-modulators in platelet-rich plasma: a comparison of the amounts in products from healthy donors and patients produced with three different techniques.

Authors:  Gianluca Ubezio; Massimo Ghio; Paola Contini; Roberta Bertorello; Gennaro Marino; Andrea Tomasini; Gino Tripodi
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

6.  Increased serum concentrations of soluble HLA-class I antigens in hepatitis C virus related mixed cryoglobulinaemia.

Authors:  S Migliaresi; A Bresciani; L Ambrosone; M Spera; D Barbarulo; V Lombari; G Pirozzi; G Borgia; M L Lombardi; G Tirri; C Manzo
Journal:  Ann Rheum Dis       Date:  2000-01       Impact factor: 19.103

7.  Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders.

Authors:  M Hagihara; T Shimura; K Takebe; B Munkhbat; K Hosoi; T Kagawa; N Watanabe; S Matsuzaki; K Yamamoto; K Sato; K Tsuji
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

8.  Behavior of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response?

Authors:  F Puppo; A Picciotto; S Brenci; G Varagona; M Scudeletti; M Ghio; V Balestra; G Celle; F Indiveri
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

9.  Silencing of B cell receptor signals in human naive B cells.

Authors:  Niklas Feldhahn; Ines Schwering; Sanggyu Lee; Maria Wartenberg; Florian Klein; Hui Wang; Guolin Zhou; San Ming Wang; Janet D Rowley; Jürgen Hescheler; Martin Krönke; Klaus Rajewsky; Ralf Küppers; Markus Müschen
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307

10.  Serum and urine soluble HLA class I antigen concentrations are increased in patients with hemorrhagic fever with renal syndrome.

Authors:  C W Park; S N Yun; C W Yang; T G Kim; H Han; E J Choi; Y S Chang; B K Bang
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.